Global and China Antifungal Drug Market Insights, Forecast to 2026

Publisher Name :
Date: 17-Sep-2020
No. of pages: 149
Inquire Before Buying

Antifungal Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antifungal Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Antifungal Drug market is segmented into

- Echinocandins

- Azoles

- Ployenes

- Allylamines

Segment by Application, the Antifungal Drug market is segmented into

- Aspergillosis

- Dermatophytosis

- Candidiasis

Regional and Country-level Analysis

The Antifungal Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Antifungal Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Antifungal Drug Market Share Analysis

Antifungal Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antifungal Drug business, the date to enter into the Antifungal Drug market, Antifungal Drug product introduction, recent developments, etc.

The major vendors covered:

- Asperqillus

- Alternaria

- Abbott Laboratories

- Pfizer

- Glaxosmithkline

- Bayer Healthcare

- Novartis

- Sanofi-Aventis

- Merck & Co.

- Kramer Laboratories

- Enzon Pharmaceuticals

- Gilead

Global and China Antifungal Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antifungal Drug Product Introduction
1.2 Market Segments
1.3 Key Antifungal Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antifungal Drug Market Size Growth Rate by Type
1.4.2 Echinocandins
1.4.3 Azoles
1.4.4 Ployenes
1.4.5 Allylamines
1.5 Market by Application
1.5.1 Global Antifungal Drug Market Size Growth Rate by Application
1.5.2 Aspergillosis
1.5.3 Dermatophytosis
1.5.4 Candidiasis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antifungal Drug Market Size, Estimates and Forecasts
2.1.1 Global Antifungal Drug Revenue 2015-2026
2.1.2 Global Antifungal Drug Sales 2015-2026
2.2 Global Antifungal Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Antifungal Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Antifungal Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Antifungal Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Antifungal Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Antifungal Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Antifungal Drug Revenue Forecast by Region (2021-2026)
3 Global Antifungal Drug Competitor Landscape by Players
3.1 Global Top Antifungal Drug Sales by Manufacturers
3.1.1 Global Antifungal Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Antifungal Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Antifungal Drug Manufacturers by Revenue
3.2.1 Global Antifungal Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Antifungal Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antifungal Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antifungal Drug Revenue in 2019
3.2.5 Global Antifungal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antifungal Drug Price by Manufacturers
3.4 Global Antifungal Drug Manufacturing Base Distribution, Product Types
3.4.1 Antifungal Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antifungal Drug Product Type
3.4.3 Date of International Manufacturers Enter into Antifungal Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antifungal Drug Market Size by Type (2015-2020)
4.1.1 Global Antifungal Drug Sales by Type (2015-2020)
4.1.2 Global Antifungal Drug Revenue by Type (2015-2020)
4.1.3 Antifungal Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antifungal Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Antifungal Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Antifungal Drug Revenue Forecast by Type (2021-2026)
4.2.3 Antifungal Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antifungal Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antifungal Drug Market Size by Application (2015-2020)
5.1.1 Global Antifungal Drug Sales by Application (2015-2020)
5.1.2 Global Antifungal Drug Revenue by Application (2015-2020)
5.1.3 Antifungal Drug Price by Application (2015-2020)
5.2 Antifungal Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Antifungal Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Antifungal Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Antifungal Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Antifungal Drug Market Size YoY Growth 2015-2026
6.1.1 China Antifungal Drug Sales YoY Growth 2015-2026
6.1.2 China Antifungal Drug Revenue YoY Growth 2015-2026
6.1.3 China Antifungal Drug Market Share in Global Market 2015-2026
6.2 China Antifungal Drug Market Size by Players (International and Local Players)
6.2.1 China Top Antifungal Drug Players by Sales (2015-2020)
6.2.2 China Top Antifungal Drug Players by Revenue (2015-2020)
6.3 China Antifungal Drug Historic Market Review by Type (2015-2020)
6.3.1 China Antifungal Drug Sales Market Share by Type (2015-2020)
6.3.2 China Antifungal Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Antifungal Drug Price by Type (2015-2020)
6.4 China Antifungal Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Antifungal Drug Sales Forecast by Type (2021-2026)
6.4.2 China Antifungal Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Antifungal Drug Price Forecast by Type (2021-2026)
6.5 China Antifungal Drug Historic Market Review by Application (2015-2020)
6.5.1 China Antifungal Drug Sales Market Share by Application (2015-2020)
6.5.2 China Antifungal Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Antifungal Drug Price by Application (2015-2020)
6.6 China Antifungal Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Antifungal Drug Sales Forecast by Application (2021-2026)
6.6.2 China Antifungal Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Antifungal Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Antifungal Drug Market Size YoY Growth 2015-2026
7.2 North America Antifungal Drug Market Facts & Figures by Country
7.2.1 North America Antifungal Drug Sales by Country (2015-2020)
7.2.2 North America Antifungal Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Antifungal Drug Market Size YoY Growth 2015-2026
8.2 Europe Antifungal Drug Market Facts & Figures by Country
8.2.1 Europe Antifungal Drug Sales by Country
8.2.2 Europe Antifungal Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antifungal Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Antifungal Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Antifungal Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Antifungal Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Antifungal Drug Market Size YoY Growth 2015-2026
10.2 Latin America Antifungal Drug Market Facts & Figures by Country
10.2.1 Latin America Antifungal Drug Sales by Country
10.2.2 Latin America Antifungal Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antifungal Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Antifungal Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Antifungal Drug Sales by Country
11.2.2 Middle East and Africa Antifungal Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Asperqillus
12.1.1 Asperqillus Corporation Information
12.1.2 Asperqillus Description and Business Overview
12.1.3 Asperqillus Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Asperqillus Antifungal Drug Products Offered
12.1.5 Asperqillus Recent Development
12.2 Alternaria
12.2.1 Alternaria Corporation Information
12.2.2 Alternaria Description and Business Overview
12.2.3 Alternaria Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alternaria Antifungal Drug Products Offered
12.2.5 Alternaria Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Corporation Information
12.3.2 Abbott Laboratories Description and Business Overview
12.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Laboratories Antifungal Drug Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Antifungal Drug Products Offered
12.4.5 Pfizer Recent Development
12.5 Glaxosmithkline
12.5.1 Glaxosmithkline Corporation Information
12.5.2 Glaxosmithkline Description and Business Overview
12.5.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Glaxosmithkline Antifungal Drug Products Offered
12.5.5 Glaxosmithkline Recent Development
12.6 Bayer Healthcare
12.6.1 Bayer Healthcare Corporation Information
12.6.2 Bayer Healthcare Description and Business Overview
12.6.3 Bayer Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bayer Healthcare Antifungal Drug Products Offered
12.6.5 Bayer Healthcare Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Description and Business Overview
12.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis Antifungal Drug Products Offered
12.7.5 Novartis Recent Development
12.8 Sanofi-Aventis
12.8.1 Sanofi-Aventis Corporation Information
12.8.2 Sanofi-Aventis Description and Business Overview
12.8.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi-Aventis Antifungal Drug Products Offered
12.8.5 Sanofi-Aventis Recent Development
12.9 Merck & Co.
12.9.1 Merck & Co. Corporation Information
12.9.2 Merck & Co. Description and Business Overview
12.9.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Merck & Co. Antifungal Drug Products Offered
12.9.5 Merck & Co. Recent Development
12.10 Kramer Laboratories
12.10.1 Kramer Laboratories Corporation Information
12.10.2 Kramer Laboratories Description and Business Overview
12.10.3 Kramer Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Kramer Laboratories Antifungal Drug Products Offered
12.10.5 Kramer Laboratories Recent Development
12.11 Asperqillus
12.11.1 Asperqillus Corporation Information
12.11.2 Asperqillus Description and Business Overview
12.11.3 Asperqillus Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Asperqillus Antifungal Drug Products Offered
12.11.5 Asperqillus Recent Development
12.12 Gilead
12.12.1 Gilead Corporation Information
12.12.2 Gilead Description and Business Overview
12.12.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Gilead Products Offered
12.12.5 Gilead Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antifungal Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antifungal Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Antifungal Drug Market Segments
Table 2. Ranking of Global Top Antifungal Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antifungal Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Echinocandins
Table 5. Major Manufacturers of Azoles
Table 6. Major Manufacturers of Ployenes
Table 7. Major Manufacturers of Allylamines
Table 8. Global Antifungal Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Antifungal Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Antifungal Drug Sales by Regions 2015-2020 (K Units)
Table 11. Global Antifungal Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Antifungal Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Antifungal Drug Sales Forecast by Region (2021-2026) (K Units)
Table 14. Global Antifungal Drug Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Antifungal Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Antifungal Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Antifungal Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifungal Drug as of 2019)
Table 18. Antifungal Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Antifungal Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Antifungal Drug Price (2015-2020) (USD/Unit)
Table 21. Antifungal Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Antifungal Drug Product Type
Table 23. Date of International Manufacturers Enter into Antifungal Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Antifungal Drug Sales by Type (2015-2020) (K Units)
Table 26. Global Antifungal Drug Sales Share by Type (2015-2020)
Table 27. Global Antifungal Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Antifungal Drug Revenue Share by Type (2015-2020)
Table 29. Antifungal Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Antifungal Drug Sales Share by Type (2021-2026)
Table 31. Global Antifungal Drug Sales by Application (2015-2020) (K Units)
Table 32. Global Antifungal Drug Sales Share by Application (2015-2020)
Table 33. Global Antifungal Drug Sales Share by Application (2021-2026)
Table 34. Global Antifungal Drug Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Antifungal Drug Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Antifungal Drug Revenue Market Share Forecast by Application (2021-2026)
Table 37. China Antifungal Drug Sales (K Units) of Key Companies (2015-2020)
Table 38. China Antifungal Drug Sales Share by Company (2015-2020)
Table 39. China Antifungal Drug Revenue (US$ Million) by Company (2015-2020)
Table 40. China Antifungal Drug Sales (K Units) by Type (2015-2020)
Table 41. China Antifungal Drug Sales Share by Type (2015-2020)
Table 42. China Antifungal Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. China Antifungal Drug Price (K Units) by Type (2015-2020)
Table 44. China Antifungal Drug Sales (K Units) by Type (2021-2026)
Table 45. China Antifungal Drug Sales Share by Type (2021-2026)
Table 46. China Antifungal Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. China Antifungal Drug Revenue Share by Type (2021-2026)
Table 48. China Antifungal Drug Price (K Units) by Type (2021-2026)
Table 49. China Antifungal Drug Sales (K Units) by Application (2015-2020)
Table 50. China Antifungal Drug Sales Share by Application (2015-2020)
Table 51. China Antifungal Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. China Antifungal Drug Sales (K Units) by Application (2021-2026)
Table 53. China Antifungal Drug Sales Share by Application (2021-2026)
Table 54. China Antifungal Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. China Antifungal Drug Revenue Share by Application (2021-2026)
Table 56. North America Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 57. North America Antifungal Drug Sales Market Share by Country (2015-2020)
Table 58. North America Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 60. Europe Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 61. Europe Antifungal Drug Sales Market Share by Country (2015-2020)
Table 62. Europe Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Antifungal Drug Sales by Region (2015-2020) (K Units)
Table 65. Asia Pacific Antifungal Drug Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Antifungal Drug Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Antifungal Drug Revenue Market Share by Region (2015-2020)
Table 68. Latin America Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 69. Latin America Antifungal Drug Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 73. Middle East and Africa Antifungal Drug Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 76. Asperqillus Corporation Information
Table 77. Asperqillus Description and Business Overview
Table 78. Asperqillus Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Asperqillus Antifungal Drug Product
Table 80. Asperqillus Recent Development
Table 81. Alternaria Corporation Information
Table 82. Alternaria Description and Business Overview
Table 83. Alternaria Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Alternaria Product
Table 85. Alternaria Recent Development
Table 86. Abbott Laboratories Corporation Information
Table 87. Abbott Laboratories Description and Business Overview
Table 88. Abbott Laboratories Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Abbott Laboratories Product
Table 90. Abbott Laboratories Recent Development
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Business Overview
Table 93. Pfizer Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Pfizer Product
Table 95. Pfizer Recent Development
Table 96. Glaxosmithkline Corporation Information
Table 97. Glaxosmithkline Description and Business Overview
Table 98. Glaxosmithkline Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Glaxosmithkline Product
Table 100. Glaxosmithkline Recent Development
Table 101. Bayer Healthcare Corporation Information
Table 102. Bayer Healthcare Description and Business Overview
Table 103. Bayer Healthcare Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Bayer Healthcare Product
Table 105. Bayer Healthcare Recent Development
Table 106. Novartis Corporation Information
Table 107. Novartis Description and Business Overview
Table 108. Novartis Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Novartis Product
Table 110. Novartis Recent Development
Table 111. Sanofi-Aventis Corporation Information
Table 112. Sanofi-Aventis Description and Business Overview
Table 113. Sanofi-Aventis Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Sanofi-Aventis Product
Table 115. Sanofi-Aventis Recent Development
Table 116. Merck & Co. Corporation Information
Table 117. Merck & Co. Description and Business Overview
Table 118. Merck & Co. Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Merck & Co. Product
Table 120. Merck & Co. Recent Development
Table 121. Kramer Laboratories Corporation Information
Table 122. Kramer Laboratories Description and Business Overview
Table 123. Kramer Laboratories Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Kramer Laboratories Product
Table 125. Kramer Laboratories Recent Development
Table 126. Enzon Pharmaceuticals Corporation Information
Table 127. Enzon Pharmaceuticals Description and Business Overview
Table 128. Enzon Pharmaceuticals Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Enzon Pharmaceuticals Product
Table 130. Enzon Pharmaceuticals Recent Development
Table 131. Gilead Corporation Information
Table 132. Gilead Description and Business Overview
Table 133. Gilead Antifungal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Gilead Product
Table 135. Gilead Recent Development
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Antifungal Drug Players
Table 140. Antifungal Drug Customers List
Table 141. Antifungal Drug Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Antifungal Drug Product Picture
Figure 2. Global Antifungal Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Echinocandins Product Picture
Figure 4. Azoles Product Picture
Figure 5. Ployenes Product Picture
Figure 6. Allylamines Product Picture
Figure 7. Global Antifungal Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Aspergillosis
Figure 9. Dermatophytosis
Figure 10. Candidiasis
Figure 11. Antifungal Drug Report Years Considered
Figure 12. Global Antifungal Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Antifungal Drug Sales 2015-2026 (K Units)
Figure 14. Global Antifungal Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antifungal Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Antifungal Drug Sales Market Share by Region in 2019
Figure 17. Global Antifungal Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Antifungal Drug Revenue Market Share by Region in 2019
Figure 19. Global Antifungal Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antifungal Drug Revenue in 2019
Figure 21. Antifungal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antifungal Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Antifungal Drug Sales Market Share by Type in 2019
Figure 24. Global Antifungal Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Antifungal Drug Revenue Market Share by Type in 2019
Figure 26. Global Antifungal Drug Market Share by Price Range (2015-2020)
Figure 27. Global Antifungal Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Antifungal Drug Sales Market Share by Application in 2019
Figure 29. Global Antifungal Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Antifungal Drug Revenue Market Share by Application in 2019
Figure 31. China Antifungal Drug Sales Growth Rate 2015-2026 (K Units)
Figure 32. China Antifungal Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. China Antifungal Drug Market Share in Global Market 2015-2026
Figure 34. China 5 and 10 Largest Antifungal Drug Players Market Share by Revenue in Antifungal Drug in 2019
Figure 35. China Antifungal Drug Revenue Share by Type (2015-2020)
Figure 36. China Antifungal Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 37. China Antifungal Drug Revenue Share by Application (2015-2020)
Figure 38. China Antifungal Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Antifungal Drug Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Antifungal Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Antifungal Drug Sales Market Share by Country in 2019
Figure 42. North America Antifungal Drug Revenue Market Share by Country in 2019
Figure 43. U.S. Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Antifungal Drug Sales Growth Rate 2015-2020 (K Units)
Figure 48. Europe Antifungal Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Antifungal Drug Sales Market Share by Country in 2019
Figure 50. Europe Antifungal Drug Revenue Market Share by Country in 2019
Figure 51. Germany Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Germany Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. France Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 56. U.K. Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 58. Italy Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 60. Russia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Antifungal Drug Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Antifungal Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Antifungal Drug Sales Market Share by Region in 2019
Figure 64. Asia Pacific Antifungal Drug Revenue Market Share by Region in 2019
Figure 65. China Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Antifungal Drug Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Antifungal Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Antifungal Drug Sales Market Share by Country in 2019
Figure 90. Latin America Antifungal Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Antifungal Drug Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Antifungal Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antifungal Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antifungal Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Antifungal Drug Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
  • Global and Japan POC Infectious Diseases Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 95
    Global POC Infectious Diseases Scope and Market Size POC Infectious Diseases market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global POC Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product c......
  • Global and China Photomedicine Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 131
    Global Photomedicine Scope and Market Size Photomedicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Photomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split into - Skin......
  • Global and Japan Pediatric Medicines Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 140
    Pediatric Medicines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Pediatric Medicines market is seg......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 146
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 142
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 126
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • (Post-pandemic Era) - Global Protein Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 26-Oct-2020        Price: US 4860 Onwards        Pages: 103
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Protein Drugs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related reg......
  • (Post-pandemic Era) - Global Protein Drugs Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 134
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Protein Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 138
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs